
Keywords: Intratumour heterogeneity; Drug resistance; Genomic instability; Cancer evolutionWES, whole exome sequencing; WGS, whole genome sequencing; ITH, intratumour heterogeneity; RNAseq, whole transcriptome sequencing; CGH, comparative genomic hybridisation; ctD